Osteodystrophy in Continuous Ambulatory Peritoneal Dialysis

Malluche H.H. , Ritz E. , Kutschera J. Bone histology in incipient and advanced renal failure. Kidney Int 1976; 9: 355–62.

Kanis J.A. , Cundy T. , Hamdy N.A.T. Renal osteodystrophy. In: Martin T.J. , ed. Metabolic bone disease. Clin Endocrinol Metab 1988; 2: 193–241.

Ellis H.A. , Pierides A.M. , Feest T.G. , Ward M.K. , Kerr D.N.S. Histophathology of renal osteodystrophy with particular reference to the effects of la hydroxy vitamin D3 in patients treated by long-term dialysis. Clin Endocrinol 1977; 7: 31S–38S.

Kanis J.A. Osteomalacia and chronic renal failure. J Clin Pathol 1981; 34: 1295–307.

Charhon S.A. , Chavassieux P.M. , Chapuy M.C. , Boivin G.Y. , Meunier P.J. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. J Lab Clin Med 1985; 106: 123–31.

Mirahmady K.S. , Duffy B.S. , Shinaberger J.H. A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis. Trans Am SocArtiflntern Organs 1971; 17: 118–22.

Neff M.S. , Eiser A.R. , Slifkin R.F. Patients surviving ten years on hemodialysis. Am J Med 1983; 74: 996–1004.

Piraino B.M. , Rault R. , Dominguez J.H. , Puschett J.B. Renal osteodystrophy in patients on hemodialysis for more than ten years. Miner Electrolyte Metab 1986; 12: 390–6.

Nolph K.D. , Sorkin M. , Rubin J. Continuous ambulatory peritoneal dialysis: Three-year experience at one center. Ann Intern Med 1980; 92: 609–13.

Gokal R. , Fryer R. , McHugh M. , Ward M.K. , Kerr D.N.S. Calcium and phosphate control in CAPD patients. In: Legrain M. , ed. CAPD Amsterdam: Excerpta Medica, 1980: 283–91.

Ramos J.M. , Gokal R. , Siamopolous K. Continuous ambulatory peritoneal dialysis: Three years’ experience. Q J Med 1983; 206: 165–86.

Rahmann R. , Heaton A. , Goodship T.H.J. Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis: A five-year study. Perit Dial Bull 1987; 7: 20–6.

Kurtz H.E. , McCarthy J.T. , Kumar R. Hypercalcaemia in continuous ambulatory peritoneal dialysis (CAPD) patients: Observations on parameters of calcium metabolism. In: Advances in peritoneal dialysis. Amsterdam: Excerpta Medica 1981: 467–72.

Nolph K.D. , Prowant B. , Serkes K.D. Multicenter evaluation of a new peritoneal dialysis solution with a high lactate and a low magnesium concentration. Perit Dial Bull 1983; 3: 63–5.

Parker A. , Nolph K. Magnesium and calcium mass transfer during continuous ambulatory peritoneal dialysis. Trans Am Soc Artif Intern Organs 1980; 26: 194–6.

Delmez J.A. , Slatopolsky E. , Martin K.J. , Gearing B.N. , Harter H.R. Minerals, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis. KidneyInt 1982; 21: 862–7.

Cassidy M.J.D. , Owen J.P. , Ellis H.A. Renal osteodystrophy and metastatic calcification in long-term continuous ambulatory peritoneal dialysis. Q J Med 1985; 54: 29–48.

Williams P. , Kay R. , Harrison J. Nutritional and anthropometric assessment of patients on CAPD over one year: Contrasting changes in total body nitrogen and potassium. PeritDialBull 1981; 1: 82–7.

Heide B. , Pierratos A. , Khanna R. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1983; 3: 138–41.

Lindholm B. , Bergstrom J. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1988; 30: S59–63.

Katirtzoglou A. , Oreopoulos D.G. , Husdan H. Reappraisal of protein losses in patients undergoing CAPD. Nephron 1980; 26: 230–3.

Blumenkrantz M.J. , Gahl G.M. , Kopple J.D. Protein losses during peritoneal dialysis. Kidney Int 1981; 19: 593–602.

Rubin J. , Nolph K.D. , Arfania D. Protein losses in continuous peritoneal dialysis. Nephron 1981; 28: 21821.

Gokal R. , Ramos J.M. , Ellis H.A. Histological renal osteodystrophy and 25-hydroxy-cholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis. Kidney Int 1983; 23: 15–21.

Aloni Y. , Shany S. , Chaimovitz C. Losses of 25 hydroxyvitamin D in peritoneal fluid: Possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis. Miner Electrolyte Metab 1983; 9: 82–6.

Digenis G. , Khanna R. , Pierratos A. Renal os teodystrophy in patients maintained on CAPD for more than three years. Perit Dial Bull 1983; 3: 81–6.

Tielemans C. , Aubry C. , Dratwa M. The effects of oontinuous ambulatory peritoneal dialysis (CAPD) on renal osteodystrophy. In: Gah1 G.M. , Kessel M. , Nolph K.D. , eds. Advances in peritoneal dialysis. Amsterdam: Excerpta Medica, 1981: 455–60.

Shany S. , Rapoport J. , Goligorsky M. Losses of 1,25 and 24-25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis. Nephron 1984; 36: 111–13.

Shusterman N.H. , Wasserstein A.G. , Morrison G. Controlled study of renal osteodystrophy in patients undergoing dialysis: Improved response to oontinuous ambulatory peritoneal dialysis compared with hemodialysis. Am J Med 1987; 82: 1148–56.

Nolph K.D. , Ryan L. , Prowant B. , Twardowski Z. A cross-sectional assessment of serum vitamin D and triglycerides in a CAPD population. Perit Dial Bull 1984; 4: 232.

Moncrieff J.W. , Popovich R.P. , Nolph K.D. Additional experience with continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978; 24: 476–83.

Oreopoulos D.G. , Robson M. , Faller B. Continuous ambulatory peritoneal dialysis: A new era in the treatment of chronic renal failure. Clin Nephrol 1979; 11: 125.

Calderaro V. , Oreopoulos D.G. , Meema H.E. The evolution of renal osteodystrophy in patients undergoing CAPD. Proc EDTA 1980; 17: 533–42.

Delmez J.A. , Fallon M.D. , Bergfeld M.A. Continuous ambulatory peritoneal dialysis and bone. Kidney Int 1986; 30: 379–84.

Buccianti G. , Bianchi M.L. , Valenti G. Progress of renal osteodystrophy during oontinuous ambulatory peritoneal dialysis. Clin Nephrol 1984; 22: 279–83.

Zuchelli P. , Catizone L. , Casanova S. Renal osteodystrophy in CAPD patients. Miner Electrolyte Metab 1984; 10: 326–32.

Loschiavo C. , Fabris A. , Adami S. Effects of oontinuous ambulatory peritoneal dialysis (CAPD) on renal osteodystrophy. Perit Dial Bull 1985; 5: 53–5.

Delmez J. , Slatopolsky E. , Martin K. , Gearing B. , Harter H. The effects of continuous ambulatory peritoneal dialysis (CAPD) on parathyroid hormone (PTH) and mineral metabolism. Kidney Int 1981; 19: 145.

Bergstrom J. , Ababa H. , Furst P. , Lindholm B. Middle molecules in chronic uremic patients treated with peritoneal dialysis. In: Gahl G.M. , Kessel M. , Nolph K.D. , eds. Advances in peritoneal dialysis. Amsterdam: Excerpta Medica, 1982: 47–53.

Oreopoulos D.G. , Pitel S. , Husdan H. Contrasting effects of hemodialysis and peritoneal dialysis on the inhibition of in vitro calcification by uremic serom. Can Med Assoc J 1974; 110: 43–7.

Hamdy N.A.T. , Boletis J. , Charlesworth D. , Kanis J.A. , Brown C.B. Low-calcium dialysate increases the tolerance to vitamin D in peritoneal dialysis. Contrib Nephrol 1991; 89: 190–8.

Nordin BEC. Calcium, phosphate and magnesium metabolism. London and New York: Churchill Livingstone, 1976.

Kanis J.A. , Hamdy N.A.T. , McCloskey E.V. Hypocalcaemia and hypercalcaemia. In: Oxford textbook of clinical nephrology. Oxford: Oxford University Press (in press).